Steven R. Watt is the current CEO at Atterx BioTherapeutics. Steven has over 20 years of experience in the biotech industry. Steven was the Chief Operating Officer at Atterx Biotherapeutics from January 2006 to December 2016. Prior to that, they were the Director of Cell Biology and Transgenesis at Infigen from January 1999 to December 2004. Steven has a wealth of experience in the biotech industry and is a well-respected leader in the field.
Steven R. Watt received a PhD in Bacteriology & Biochemistry from the University of Guelph.
Some direct reports include Lisa Beth Ferstenberg - Acting Chief Medical Officer, James V. Millar - Acting CFO.
Org chart
Sign up to view 2 direct reports
Get started